Urinary Bladder Cancer

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

Intravesical Gem/Doce in Patients With NMIBC

Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer

Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Predictive Role of Microbiome in Patients With Urothelial Carcinoma

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Patterns of Urinary Bladder Cancer in Darfur, Suda

Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy

Physical Rehabilitation Among Patients Undergoing Radical Cystectomy Due to Urinary Bladder Cancer

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma